The Journal of Organic Chemistry · 2001 · 39 citations · 20 references
Natural SciencesChemistryMedicinal ChemistryDrug DiscoveryOrganic ChemistrySynthetic Medicinal ChemistryHeterocycle SynthesisHeterocyclic ChemistryMacrocycle SynthesisOrganic SynthesisRetrosynthetic AnalysisAcidic DeprotectionDeprotection StrategyNucleoside Analog SynthesisNucleoside AnalogsNucleoside ModificationPurine ChemistryRibonucleoside ChemistryStereocontrolled Library Synthesis
Carbocyclic 9-deazapurine nucleosides (1-4), a spiranic pyrimidone carbocyclic compound (5), and an unusual carbocyclic isonucleoside (6) were prepared as enantiomerically pure compounds via the key intermediates 10 and 21 from 1,4-gamma-ribonolactone. The key intermediate 10 was prepared by stereoselective reduction with Bu3SnH and then converted to carbocyclic C-ribonucleosides 1, 3, and 4. 2',3'-Didehydro-2',3'-dideoxycarbocyclic 9-deazainosine (2) was prepared from a 2',3'-dimesylate 17 by treatment with Li2Te followed by an acidic deprotection. The key bicyclic intermediate 21 was prepared from a diol 20 by an intramolecular cyclization using CHI3-Ph3P-imidazole and converted to the spiranic compound 5 and an olefinic nucleoside 6 by the construction of the heterocyclic moiety followed by deprotection.
20
STREPTOMYCES CITRICOLOR NOV. SP. AND A NEW ANTIBIOTIC, ARISTEROMYCIN
Taiki Kusaka, Hiroichi Yamamoto, Motoo Shibata et al. · The Journal of Antibiotics · 1968 · 206 citations · Full text